Search results for “Globulin” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 11,909 patents, we discovered top 468 key players by total patent application. Regeneron Pharmaceuticals, Inc., Ablynx NV, F. Hoffmann-La Roche Ltd. are dominant in this area. They take 9.69% of the total patent filing.
New York, United States
Patent: 544
Oost-Vlaanderen, Belgium
Patent: 380
Switzerland
Patent: 230
South Korea
Patent: 223
Hessen, Germany
Patent: 149
New York, United States
Patent: 130
California, United States
Patent: 130
New York, United States
Patent: 112
France
Patent: 106
California, United States
Patent: 103
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 354 patents, we discovered top 62 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, GI Innovation, Inc., Navigo Proteins GmbH are active in this area.
STARTUP
France
Patent: 59
STARTUP
South Korea
Patent: 56
STARTUP
Niedersachsen, Germany
Patent: 39
STARTUP
Massachusetts, United States
Patent: 19
STARTUP
South Korea
Patent: 12
STARTUP
United States
Patent: 11
STARTUP
Bayern, Germany
Patent: 11
STARTUP
United Kingdom
Patent: 9
STARTUP
California, United States
Patent: 8
STARTUP
ZURICH, Switzerland
Patent: 8
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5,694 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Ablynx NV, Bristol Myers Squibb Co. take 8.90% of patent filing during this period.
New York, United States
Patent: 209
Oost-Vlaanderen, Belgium
Patent: 204
New York, United States
Patent: 94
France
Patent: 91
South Korea
Patent: 90
California, United States
Patent: 78
New York, United States
Patent: 74
Hessen, Germany
Patent: 59
Belgium
Patent: 59
STARTUP
South Korea
Patent: 56
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5,694 patents in last 5 years, we discover 239 new entrants. Five Prime Therapeutics, Inc., GI Innovation, Inc., Momenta Pharmaceuticals, Inc. are the most active new entrants in this area.
California, United States
Patent: 78
STARTUP
South Korea
Patent: 56
Massachusetts, United States
Patent: 39
California, United States
Patent: 34
Pennsylvania, United States
Patent: 31
United States
Patent: 28
Beijing Shi, China
Patent: 27
South Korea
Patent: 25
DUBLIN, Ireland
Patent: 25
France
Patent: 23
Research Institutions
Order by:
Innovation Intensity
With the analysis among 2,542 patents, we discovered top 258 universities and scientific research institutions by total patent application. Vlaams Instituut voor Biotechnologie - Flanders Institute, The Scripps Research Institute, Baylor College of Medicine are dominant in this area. They take 8.46% of the total patent filing.
Belgium
Patent: 55
California, United States
Patent: 37
Texas, United States
Patent: 34
ZURICH, Switzerland
Patent: 31
New Hampshire, United States
Patent: 28
Oost-Vlaanderen, Belgium
Patent: 27
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 26
France
Patent: 23
United Kingdom
Patent: 22
Massachusetts, United States
Patent: 22
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: